To learn more, contact KransResearchGroup@upmc.edu.

IMPACT

Comparing effectiveness of web-based reproductive planning decision support tool to standard of care information for prenatal and postpartum women with substance use disorders.

Primary Investigator(s)

Dr. Elizabeth Krans

Sponsor

NIDA

OPTIMIZE

Evaluating the impact of integrated behavioral health treatment with substance use disorder (SUD) treatment in the perinatal period.

Primary Investigator(s)

Hollis Laird, RN

Sponsor

MWRI - Scaife - Magee CARES 2024

MOMI+

An extension of the MOMI Biobank that specifically recruits pregnant people with substance exposure. The purpose of this biobank is to develop a repository of specimens with documented substance exposure for future research.

Primary Investigator(s)

Dr. Elizabeth Krans

Sponsor

MWRI - Scaife

HOPE

This study seeks to understand the impact of substance exposure on placental and infant development through the collection of biospecimens and self-reported substance use data.

Primary Investigator(s)

Drs. Elizabeth Krans

Sponsor

NIDA

STEPuP

This study will test the effectiveness of a prenatal provider education and training program designed to facilitate provider adoption of evidence-based practices for the treatment of OUD during pregnancy. Findings from this research will provide high-quality evidence about how to increase evidence-based treatment for pregnant women with OUD and subsequent maternal-child health outcomes.

Primary Investigator(s)

Drs. Elizabeth Krans; Marian Jarlenski

Sponsor

NIH

Recovery Registry

This is an ongoing research registry for individuals interested in substance use related research opportunities.

Primary Investigator(s)

Dr. Elizabeth Krans

Sponsor

None